GLP-1 medications, including Ozempic®, Wegovy®, Mounjaro® and Zepbound®, are helping millions of people manage type 2 diabetes and obesity. About 6% of U.S. adults now take these medications to improve blood sugar control, support weight loss and lower their risk of other health conditions.¹ As their use continues to grow, many people have questions about potential side effects, including whether these medications can affect vision.
The good news is that most people taking GLP-1 medications won't experience serious eye problems. In fact, for people with diabetes, improving blood sugar control can help reduce the risk of long-term complications like diabetic retinopathy, a leading cause of vision loss.²
Still, there are a few important things to know about how these medications may affect your eyes, particularly during the first few months of treatment. Understanding what to watch for can help you protect your eye health while getting the benefits of these medications.
How can GLP-1 medications affect your vision?
Some people notice blurry vision shortly after starting a GLP-1 medication or increasing their dose. This usually isn't caused by damage to the eye itself. Instead, as blood sugar levels improve (especially if they improve quickly) the eye's natural lens can temporarily change shape, making it difficult to focus. ³
While this can be frustrating, these vision changes are typically temporary and often improve as blood sugar levels stabilize.
For people who already have diabetic retinopathy, rapid improvements in blood sugar may also temporarily worsen the condition. This isn't unique to GLP-1 medications and can happen with any treatment that significantly improves blood sugar control. Over time, maintaining healthy blood sugar remains one of the best ways to protect long-term eye health. ²
Preventive eye care plays an important role
Whether you're taking a GLP-1 medication for diabetes or weight management, routine comprehensive eye exams are one of the best ways to protect your vision.
If you have diabetes, annual dilated retinal exams can detect early signs of diabetic retinopathy before you notice changes in your vision. Your eye doctor may recommend closer monitoring when you begin a GLP-1 medication, especially if you already have diabetic eye disease. ²
Dr. Lahr's perspective
Even if you don't have diabetes, regular eye exams remain an important part of preventive health and can help detect many eye conditions before symptoms develop. ³
"As GLP-1 utilization continues to grow, one of the most important messages we can reinforce is the value of preventive eye care. For people beginning these medications—particularly those with diabetes—keeping retinal exams up to date can help identify changes early and support better long-term outcomes."
— Dr. John Lahr, OD
What does the latest research say?
Researchers have been studying whether certain GLP-1 medications may be associated with a rare condition called non-arteritic anterior ischemic optic neuropathy (NAION), sometimes referred to as an "eye stroke." NAION occurs when blood flow to the optic nerve is reduced, leading to sudden vision loss. ⁴
While some studies have identified a possible association, researchers have not established that GLP-1 medications cause NAION, and the condition remains rare. More recent research suggests that additional studies are needed to better understand whether the medications themselves (or underlying health conditions such as diabetes, high blood pressure or sleep apnea) may contribute to the risk. ⁵
For most people, healthcare providers agree that the proven benefits of GLP-1 medications, including better blood sugar control, weight loss and improved cardiovascular health, far outweigh the potential risk of rare eye complications. ²
When should you seek immediate care?
Temporary blurry vision during the early stages of treatment may be expected, but some vision changes should never be ignored.
Contact an eye care provider immediately if you experience:
- Sudden vision loss in one or both eyes
- A dark, missing or blank area in your field of vision
- Sudden changes in color vision
- New flashes of light or a sudden increase in floaters
- Vision changes that are severe or continue to worsen
Sudden vision loss is a medical emergency and should be evaluated as quickly as possible.
The bottom line
GLP-1 medications have become an important tool for managing type 2 diabetes and obesity, and for most people, the benefits far outweigh the potential risks. While temporary vision changes can occur as your body adjusts, serious eye complications remain uncommon.
Want to learn more about EyeMed vision benefits or request a quote? Speak with your EyeMed rep. Or visit, eyemed.com.
*****
- "GLP-1 Receptor Agonists and Vision Risk"; American Optometric Association; aoa.org; July 10, 2025.
- "Standards of Care in Diabetes—2025"; American Diabetes Association; diabetesjournals.org; March 10, 2025.
- Mukamal, R.; "Can Ozempic Affect Eye Health? Here's What Ophthalmologists Want You to Know"; American Academy of Ophthalmology; aao.org; October 30, 2024.
- Hathaway, J.T., et al.; "Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide"; JAMA Ophthalmology; jamanetwork.com; July 3, 2024.
- Cai, C.X., et al.; "Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy"; JAMA Ophthalmology; jamanetwork.com; January 30, 2025.
